Other faiths have managed to give up their celebrations and pilgrimages. Surely we can put up with a low-key Christmas?
L’expertise universitaire, l’exigence journalistique
Articles sur Coronavirus
Affichage de 1681 à 1700 de 5486 articles
Initial studies suggest these drugs, widely taken to lower cholesterol, may also reduce the severity of COVID-19.
After more than a month of testing without a single positive case, the probability of coronavirus lurking in Victoria is vanishingly small.
With a vaccine now approved in the UK, other countries won’t be far behind. But a vaccine won’t singlehandedly ensure the virus doesn’t cross international borders when travel picks up.
A new study has shown that there are sex-based differences in how we respond to the coronavirus.
Governments can align their policies to tackle both climate change and post-pandemic recovery.
It turns out, if your crisps are sufficiently ‘niche’ and sophisticated, even they can be classed as a meal.
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
The side effects of new SARS-CoV-2 vaccines are a result of immune system activation. While uncomfortable, they are both normal and expected. They are a sign that the vaccine is working.
Combating social media disinformation regarding vaccines is critical to reversing the growth in vaccine hesitancy around the world.
In the moment, Scott Morrison’s angry denunciation of the offensive Chinese tweet about alleged Australian war crimes seemed a reasonable response.
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
As the pandemic wears on, some people struggle to keep adhering to restrictions and social distancing guidelines. There are psychological reasons for caution fatigue, and ways to overcome it.
Logistics is the unsung hero in vaccination. But here’s why it’s critical.
Portrayals of Native Americans and COVID-19 often ignore responses rooted in tribal sovereignty.
US monuments and memorials have overlooked frontline workers and people of color affected by past epidemics. Will we repeat history?
The answer could be found in death rates among the elderly.
It may be many months before COVID control measures can be eased.
This is what it’s like fighting COVID-19 the second time around.
With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial reports.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Senior Research Fellow in Global Health, University of Southampton
-
Chair in Epidemiology, Deakin University
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Public Health, University of Sheffield
-
Associate Professor, Director Cabrini Monash University Department of Nursing Research, Monash University
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professor of Medicine, University of East Anglia
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Professor of Mathematics and Statistics, University of Strathclyde
